CVE-2022-43599

Public Exploit

Description

Multiple code execution vulnerabilities exist in the IFFOutput::close() functionality of OpenImageIO Project OpenImageIO v2.4.4.2. A specially crafted ImageOutput Object can lead to a heap buffer overflow. An attacker can provide malicious input to trigger these vulnerabilities.This vulnerability arises when the `xmax` variable is set to 0xFFFF and `m_spec.format` is `TypeDesc::UINT8`

Category

8.1
CVSS
Severity: High
CVSS 3.1 •
CVSS 3.0 •
EPSS 0.26%
Third-Party Advisory talosintelligence.com Third-Party Advisory debian.org
Affected: OpenImageIO Project OpenImageIO
Published at:
Updated at:

References

Link Tags
https://talosintelligence.com/vulnerability_reports/TALOS-2022-1656 third party advisory exploit
https://www.debian.org/security/2023/dsa-5384 third party advisory
https://security.gentoo.org/glsa/202305-33

Frequently Asked Questions

What is the severity of CVE-2022-43599?
CVE-2022-43599 has been scored as a high severity vulnerability.
How to fix CVE-2022-43599?
To fix CVE-2022-43599, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2022-43599 being actively exploited in the wild?
It is possible that CVE-2022-43599 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2022-43599?
CVE-2022-43599 affects OpenImageIO Project OpenImageIO.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.